We are live on ! Find out more
CIM

Contravisory Investment Management Portfolio holdings

AUM $566M
1-Year Est. Return 42.93%
This Fund
S&P 500
This Quarter Est. Return
-0.42%
1 Year Est. Return
+42.93%
3 Year Est. Return
+129.34%
5 Year Est. Return
+198.47%
10 Year Est. Return
+603.03%
AUM
$509M
AUM Growth
-$11.4M
Cap. Flow
-$3.03M
Cap. Flow %
-0.6%
Top 10 Hldgs %
31.12%
Holding
171
New
45
Increased
34
Reduced
28
Closed
19

Top Buys

Rank Stock Value
1
HUM icon
Humana
HUM
+$12.6M
2
VMW
VMware, Inc
VMW
+$12.1M
3
LDOS icon
Leidos
LDOS
+$12M
4
BSX icon
Boston Scientific
BSX
+$11.9M
5
SOHU
Sohu.com
SOHU
+$11.2M

Sector Composition

Rank Sector Weight
1 Healthcare 18.65%
2 Financials 16.35%
3 Technology 16.25%
4 Industrials 14.23%
5 Communication Services 9.77%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
GILD icon
1
Gilead Sciences
GILD
$161B
$18.9M 3.71%
266,934
-15,856
-6% -$1.24M
PARA
2
DELISTED
Paramount Global Class B
PARA
$17.9M 3.51%
289,056
-7,914
-3% -$499K
MCO icon
3
Moody's
MCO
$81.7B
$16.6M 3.26%
209,609
-3,075
-1% -$241K
RTN
4
DELISTED
Raytheon Company
RTN
$16.1M 3.15%
162,565
-7,442
-4% -$706K
HAL icon
5
Halliburton
HAL
$27.9B
$15.3M 3.01%
260,404
+4,326
+2% +$231K
SNDK
6
DELISTED
SANDISK CORP
SNDK
$15.2M 2.98%
186,937
-59
-0% -$4.36K
MA icon
7
Mastercard
MA
$477B
$15M 2.94%
200,385
-6,455
-3% -$504K
ALV icon
8
Autoliv
ALV
$8.6B
$14.6M 2.87%
202,383
-683
-0.3% -$46.2K
AMGN icon
9
Amgen
AMGN
$203B
$14.5M 2.84%
117,483
-763
-0.6% -$92.5K
CVS icon
10
CVS Health
CVS
$137B
$14.5M 2.84%
193,309
-4,669
-2% -$330K
AIG icon
11
American International
AIG
$41.9B
$14.1M 2.78%
282,739
-1,897
-0.7% -$94.3K
CTAS icon
12
Cintas
CTAS
$82.4B
$14M 2.75%
939,464
-35,280
-4% -$521K
BAC icon
13
Bank of America
BAC
$435B
$13.8M 2.71%
801,976
+1,558
+0.2% +$26.2K
KSU
14
DELISTED
Kansas City Southern
KSU
$13.8M 2.7%
134,859
-2,906
-2% -$300K
HUM icon
15
Humana
HUM
$46.7B
$13.6M 2.67%
+120,600
New +$12.6M
IRF
16
DELISTED
INTL RECTIFIER CORP
IRF
$13.5M 2.66%
493,752
+2,259
+0.5% +$60K
ASH icon
17
Ashland
ASH
$3.04B
$13.4M 2.63%
275,378
-4,979
-2% -$234K
RTX icon
18
RTX Corp
RTX
$287B
$13.3M 2.62%
181,357
-1,334
-0.7% -$95.8K
GNTX icon
19
Gentex
GNTX
$4.88B
$13.3M 2.62%
845,722
-1,320
-0.2% -$21.1K
CVG
20
DELISTED
Convergys
CVG
$13.3M 2.61%
607,678
+3,721
+0.6% +$77.2K
VMW
21
DELISTED
VMware, Inc
VMW
$13.3M 2.61%
+123,161
New +$12.1M
INVX
22
Innovex International
INVX
$1.87B
$13.1M 2.58%
117,255
-1,184
-1% -$123K
SNI
23
DELISTED
Scripps Networks Interactive, Inc Common Class A
SNI
$12.4M 2.43%
162,929
-1,633
-1% -$127K
BSX icon
24
Boston Scientific
BSX
$65.8B
$12.2M 2.4%
+903,826
New +$11.9M
OTEX icon
25
Open Text
OTEX
$5.43B
$11.9M 2.33%
496,864
-5,596
-1% -$136K

Similar funds

Contravisory Investment Management's Q1 2014 Portfolio in Review

As of Q1 2014, Contravisory Investment Management held 171 positions worth $509M, down 2.2% from $521M the previous quarter. Its ten largest holdings account for 31% of the portfolio.

Contravisory Investment Management's Q1 2014 filing shows 45 new, 34 increased, 28 reduced and 19 closed positions. Its largest new stake was Humana: 120,600 shares worth $13.6M. The largest sale was Cincinnati Financial, an estimated $13.5M.

By sector, the portfolio is most concentrated in Healthcare at 19% of assets, up from 9.5% a quarter earlier, followed by Financials and Technology.

  • Contravisory Investment Management's largest Q1 2014 buy was Humana: 120,600 shares worth $13.6M.
  • Contravisory Investment Management added most to Halliburton in Q1 2014, an estimated $231K increase.
  • Contravisory Investment Management's biggest Q1 2014 reduction was Ford, cutting an estimated $11.3M.
  • Contravisory Investment Management fully exited Cincinnati Financial in Q1 2014, selling an estimated $13.5M.
  • Contravisory Investment Management's ten largest holdings make up 31% of its $509M portfolio in Q1 2014.
  • Contravisory Investment Management opened 45 new positions and closed 19 in Q1 2014.
  • Contravisory Investment Management's portfolio value fell 2.2% quarter-over-quarter to $509M.

Based on Contravisory Investment Management's 13F filing for Q1 2014, filed 16 Apr 2014.